Billy Wynne

🏛️ Revolving Door

Former Government Position:

Health Policy Counsel, Senate Finance Committee

Share:𝕏LinkedInFacebook
🤖

AI Overview

Billy Wynne has appeared in 306 federal lobbying filings at Impact Health Policy Partners, representing 21 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door."

306
Total Filings
1
Firms
21
Clients
0
Issue Areas

Firms

Impact Health Policy Partners0 filings

Top Clients

Abbott Laboratories0 filings
Friday Health Plans of Colorado, INC.0 filings
Hackensack Meridian Health0 filings
Cambia Health Solutions, INC.0 filings
Greater New York Hospital Association0 filings
Children's Hospital Colorado0 filings
Mercy0 filings
Parker Jewish Institute for Health Care and Rehabilitation0 filings
Thorn Run Partners on Behalf of Sunovion Pharmaceuticals INC.0 filings
Thorn Run Partners Obo Coalition for Organ Distribution Equity (Code) (Informal)0 filings
Express Scripts0 filings
National Coalition for Transplant Equity (Ncte)0 filings
Cleveland Clinic0 filings
Thorn Run Partners on Behalf of Oregon Health & Science University0 filings
Nash Alliance0 filings
Cigna Corporation0 filings
Satellite Healthcare0 filings
Sumitomo Pharma America, INC.0 filings
Society for Healthcare Epidemiology of America (Shea)0 filings
Phreesia, INC.0 filings

Related Analysis

🏛️ Revolving Door Premium
Do ex-government lobbyists earn more?
🕸️ Network Analysis
Explore connections between firms and lobbyists
🎯 Market Concentration
How concentrated is the lobbying market?

Related Investigations

The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Explore More

← All Lobbyists🏛️ Revolving Door🕸️ Network Analysis🏛️ Agency Pressure 🔍 Investigations

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.